Fig. 5.
Transition of tumor markers. After TAI with epirubicin, elevation of the tumor marker levels continued; however, after TAI with miriplatin, tumor marker levels markedly decreased and improved to nearly the normal range.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.